MyAverix Finance
US · Healthcare
Chalice Brands Ltd (CHALF)
Drug Manufacturers - Specialty & Generic
Chalice Brands Ltd (CHALF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CHALF
Chalice Brands Ltd (CHALF) — FAQ
What is CHALF's P/E ratio?
The price-to-earnings (P/E) ratio for Chalice Brands Ltd (CHALF) is 18.00 (data as of 2026-03-23).
Does Chalice Brands Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Chalice Brands Ltd (CHALF). Check the MyAverix Finance app for the latest dividend data.
What sector is Chalice Brands Ltd in?
Chalice Brands Ltd (CHALF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CHALF listed on?
CHALF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.